ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 5 filers reported holding ERYTECH PHARMA in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,606,000 | +19.4% | 625,000 | 0.0% | 0.04% | +10.3% |
| Q2 2021 | $3,019,000 | -31.4% | 625,000 | 0.0% | 0.04% | -60.6% |
| Q1 2021 | $4,400,000 | -23.7% | 625,000 | 0.0% | 0.10% | -34.9% |
| Q4 2020 | $5,769,000 | +53.8% | 625,000 | 0.0% | 0.15% | -4.4% |
| Q3 2020 | $3,750,000 | -34.4% | 625,000 | 0.0% | 0.16% | -30.9% |
| Q2 2020 | $5,719,000 | +71.3% | 625,000 | 0.0% | 0.23% | +32.2% |
| Q1 2020 | $3,338,000 | -27.5% | 625,000 | 0.0% | 0.17% | -20.2% |
| Q4 2019 | $4,606,000 | +74.2% | 625,000 | 0.0% | 0.22% | -0.5% |
| Q3 2019 | $2,644,000 | -40.8% | 625,000 | 0.0% | 0.22% | -30.0% |
| Q2 2019 | $4,469,000 | -5.7% | 625,000 | 0.0% | 0.31% | +27.2% |
| Q1 2019 | $4,738,000 | +12.0% | 625,000 | 0.0% | 0.25% | +46.4% |
| Q4 2018 | $4,231,000 | -21.0% | 625,000 | 0.0% | 0.17% | -27.3% |
| Q3 2018 | $5,356,000 | -23.3% | 625,000 | 0.0% | 0.23% | -29.4% |
| Q2 2018 | $6,981,000 | -46.8% | 625,000 | 0.0% | 0.33% | -44.0% |
| Q1 2018 | $13,125,000 | -4.6% | 625,000 | 0.0% | 0.58% | +2.5% |
| Q4 2017 | $13,763,000 | – | 625,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|